On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

Suzhou Dongshan Precision Manufacturing (DSBJ) will invest US$1.2 billion to expand optical chip and optical module capacity at Source Photonics, accelerating its shift from PCB manufacturing into AI ...

Microsoft's AI integration obsession has left a bad impression, and users can now remove Copilot using Group Policy.

Live from San Francisco, we compiled all the biggest news from Microsoft's annual developer conference. This is how Microsoft sees the future of AI computing. Microsoft Build is officially over, but ...

JEDEC has previewed the technical roadmap for the LPDDR6 memory standard, which will double individual module capacities to 512 GB using efficient SOCAMM2 form factors to support expanding Agentic AI ...

LONDON and REDMOND, Wash. — June 9, 2026 — KPMG and Microsoft Corp. on Tuesday announced an expansion of their global relationship to help clients deploy AI at scale. Under the agreement, KPMG will ...

As the global demand for AI accelerates, a new industrial challenge has emerged: the sheer scale of energy required to power the "AI factories" of the future. This concern was the centerpiece of ...

PCWorld reports Microsoft is resuming forced M365 Copilot installations after a brief pause, targeting completion by July 1st for all Microsoft 365 users. Previous forced installations caused ...

Threat actors have been disguising malware as AI study guides and developer resources to trick professionals into running a multi-stage attack that ends in the AsyncRAT trojan. New analysis from ...

Last Tuesday, Microsoft patched a vulnerability it rated as max critical in its M365 Copilot AI platform. On Monday, the researchers who discovered the vulnerability and reported it to Microsoft ...

LONDON — June 7, 2026 — NHS England on Sunday announced that it is significantly accelerating AI adoption across healthcare services by providing 505,000 clinicians and support staff with access to ...

Ignota Labs, a company based in Cambridge, UK, uses artificial-intelligence technology to determine why drugs have failed in clinical trials, before re-engineering the most promising therapies to give ...